AI Terminal
CHESNARA PLC
Director's Dealing • Apr 29, 2021
5301_dirs_2021-04-29_d338e727-d7e2-45b4-8cd6-e7218ca87a4a.html
Director's Dealing
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 9520W
Chesnara PLC
29 April 2021
CHESNARA plc
("Chesnara" or "the Company")
29 April 2021
LEI Number: 213800VFRMBRTSZ3SJ06
NOTIFICATION OF TRANSACTIONS OF DIRECTORS / PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY ('PDMRs')
Chesnara plc (the 'Company') today announces that, as at 28 April 2021, John Deane and David Rimmington (each a PDMR) were granted awards in the ordinary shares of the Company under the Chesnara plc Long Term and Short Term Schemes. These awards were made in accordance with the Directors' Remuneration Policy.
The notifications for each PDMR below, which are being made in accordance with the requirements of the EU Market Abuse Regulations, provide further detail of the awards granted to each PDMR.
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||
| a) b) |
Natural person: Legal person |
John Deane | |
| 2 | Reason for the notification | ||
| a) | Position/status: | Chief Executive Officer | |
| b) | Initial notification/amendment | Initial notification | |
| 3 | Details of the Issuer | ||
| a) | Name | Chesnara plc | |
| b) | Legal Entity Identifier: | 213800VFRMBRTSZ3SJ06 | |
| 4 | Details of the transaction(s): Parts a-d of this section are to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted. | ||
| a) | Description of the financial instrument, type of instrument (Identification code) | Chesnara plc Ordinary Shares of 5 pence each (GB00B00FPT80) |
|
| b) | Nature of the transaction | GRANT 1 Granted under the Chesnara 2014 Short-term Incentive Scheme. The option is not subject to a performance target. The option will become exercisable on 28 April 2024 and remain exercisable up to and including 27 April 2031 if not exercised before that date. GRANT 2 Granted under the Chesnara 2014 Long-term Incentive Scheme. The option is subject to a performance target over a period of three financial years. Subject to the achievement of the performance target, the option will become exercisable on 28 April 2024 and remain exercisable up to and including 27 April 2031 if not exercised before that date. |
|
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| Nil | GRANT 1 31,065 Ordinary shares of 5p each |
||
| Nil | GRANT 2 166,453 Ordinary shares of 5p each |
||
| d) | Aggregated information - Aggregated volume - Price |
- 197,518 ORDINARY SHARES OF 5P EACH - Nil |
|
| e) | Date of the transaction (YYYY - MM - DD) | 2021-04-28 | |
| f) | Place of the transaction | XOFF |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||
| a) b) |
Natural person: Legal person |
David Rimmington | |
| 2 | Reason for the notification | ||
| a) | Position/status: | Chief Finance Officer | |
| b) | Initial notification/amendment | Initial notification | |
| 3 | Details of the Issuer | ||
| a) | Name | Chesnara plc | |
| b) | Legal Entity Identifier: | 213800VFRMBRTSZ3SJ06 | |
| 4 | Details of the transaction(s): Parts a-d of this section are to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted. | ||
| a) | Description of the financial instrument, type of instrument (Identification code) | Chesnara plc Ordinary Shares of 5 pence each (GB00B00FPT80) |
|
| b) | Nature of the transaction | GRANT 1 Granted under the Chesnara 2014 Short-term Incentive Scheme. The option is not subject to a performance target. The option will become exercisable on 28 April 2024 and remain exercisable up to and including 27 April 2031 if not exercised before that date. GRANT 2 Granted under the Chesnara 2014 Long-term Incentive Scheme. The option is subject to a performance target over a period of three financial years. Subject to the achievement of the performance target, the option will become exercisable on 28 April 2024 and remain exercisable up to and including 27 April 2031 if not exercised before that date. |
|
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| Nil | GRANT 1 18,803 Ordinary shares of 5p each |
||
| Nil | GRANT 2 94,502 Ordinary shares of 5p each |
||
| d) | Aggregated information - Aggregated volume - Price |
113,305 ORDINARY SHARES OF 5P EACH Nil |
|
| e) | Date of the transaction (YYYY - MM - DD) | 2021-04-28 | |
| f) | Place of the transaction | XOFF |
Name of authorised official of issuer responsible for making notification: - Al Lonie
Date of notification: - 29 April 2021
For further information, please contact:
Roddy Watt
Director, Capital Markets
FWD
Forward thinking communications
T - 020 7280 0651
Notes to Editors
Chesnara is a life and pensions company listed on the London Stock Exchange. It administers over one million policies and operates as Countrywide Assured in the UK, as The Waard Group and Scildon in the Netherlands, and as Movestic in Sweden.
Following a three pillar strategy, Chesnara's primary responsibility is the efficient administration of its customers' life and savings policies, ensuring good customer outcomes and providing a secure and compliant environment to protect policyholder interests. It also adds value by writing profitable new business in Sweden and the Netherlands and by undertaking value-adding acquisitions of either companies or portfolios.
Consistent delivery of the Company strategy has enabled Chesnara to increase its dividend for 16 years in succession.
Further details are available on the Company's website (www.chesnara.co.uk).
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHPPUCUCUPGGCR